Josef Vormoor

Medicine · Health Sciences

46h-index12.7kcitations259works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(102), Acute Myeloid Leukemia Research(60), Hematopoietic Stem Cell Transplantation(46), Cancer Genomics and Diagnostics(37), CAR-T cell therapy research(32)

Publications259 total

Responses can be achieved with a combination of the MEK inhibitor selumetinib and dexamethasone in patients with relapsed/refractory RAS-pathway mutated acute lymphoblastic leukemia: Results of a parallel cohort, dose-finding and expansion phase I/II trial
EJC Paediatric Oncology·2026Open Access
Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia
Blood·2025· 2 citedOpen Access
Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment
Leukemia·2025· 1 citedOpen Access
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]
European Journal of Cancer·2025· 1 citedOpen Access
Supplementary Figure S3 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Table 10 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S4 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Table 2 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Table 8 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S8 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S11 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S6 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Table 5 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Table 3 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S5 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S12 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S10 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S2 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S7 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
Supplementary Figure S9 from Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
2025Open Access
page 1 of 13Next →

Frequent Co-authors

Olaf Heidenreich(14), Simon Bomken(8), Alex Elder(7), Tsvee Lapidot(6), Martin Schrappe(6), Julie Irving(6), Heribert Jürgens(6), Helen J. Blair(6), John E. Dick(5), Rob Pieters(5), Jean‐Pierre Bourquin(5), C. Michel Zwaan(4), Michael Dworzak(4), Jochen Harbott(4), Christine J. Harrison(4), Deepali Pal(4), Barbara Murdoch(3), Claus Meyer(3), Bernd Gruhn(3), Shai Izraeli(3)